Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus

E Aragon1, L P Resontoc1, Y H Chan2

  • 1Shaw-NKF-NUH Children's Kidney Centre, Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore.

Lupus
|November 6, 2015
PubMed

Insights

This study shows that a multi-targeted treatment protocol for children with severe lupus nephritis (LN) leads to long-term remission and kidney preservation. The treatment demonstrated good patient survival and a favorable safety profile over nearly a decade of follow-up.

Area of Science:

  • Pediatric Nephrology
  • Immunology
  • Rheumatology

Background:

  • Severe proliferative lupus nephritis (LN) in children poses significant risks for long-term kidney damage.
  • Previous one-year outcomes indicated efficacy of a multi-targeted induction protocol.
  • Long-term data are crucial for evaluating sustained remission and renal preservation in pediatric LN.

Purpose of the Study:

  • To assess the long-term renal outcomes in children with severe proliferative LN treated with a specific multi-targeted protocol.
  • To evaluate patient and renal survival, relapse-free survival, and event-free survival.
  • To analyze changes in clinical and laboratory parameters over an extended follow-up period.

Main Methods:

  • Retrospective analysis of 16 children with severe proliferative LN.
  • Treatment protocol included intravenous pulse methylprednisolone (MP), mycophenolate mofetil (MMF), and cyclosporine (CSA).
  • Long-term follow-up (median 9.2 years) assessed complete renal remission, survival rates, and clinical/laboratory markers.

Main Results:

  • All patients achieved complete renal remission within 24 months (median 8.7 months).
  • Significant improvements observed in SLEDAI scores, serum C3 levels, eGFR, and urine protein levels.
  • Cumulative ten-year renal relapse-free survival was 73.3%; 71.4% probability of avoiding hospitalization at ten years.

Conclusions:

  • The multi-targeted induction and maintenance therapy protocol is effective for long-term renal preservation in Asian children with severe proliferative LN.
  • The protocol demonstrates good patient survival and a favorable safety profile.
  • Sustained remission and improved renal function markers indicate the protocol's long-term benefits.

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
781
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
563
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
669